Arkolith/Insider Trading/ELEV/Form 4

Furlong Tammy

CHIEF FINANCIAL OFFICERElevation Oncology, Inc. (ELEV) · full profile →Form 4 · filed Feb 19, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
7
4 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 15, 2025Tax withholding(F)3K$0.67$2K8K
Feb 15, 2025Option exercise(M)9K——11K
Feb 15, 2025Tax withholding(F)89$0.67$608K
Feb 15, 2025Option exercise(M)300——8K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 15, 2025Grant(A)275K—$0275K
Feb 15, 2025Option exercise(M)9K—$028K
Feb 15, 2025Option exercise(M)300—$02K

Transaction Codes

F
Shares withheld for taxes
M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-004609) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML